Literature DB >> 18346407

Onycholysis associated with capecitabine in patients with breast cancer.

Marcia Hogeling1, Jessica Howard, Nordau Kanigsberg, Harvey Finkelstein.   

Abstract

BACKGROUND: Onycholysis, which is separation of the nail plate from the nail bed at its distal and lateral attachments, can cause pain and impair function and is a well-known side effect of traditional chemotherapeutic agents.
OBJECTIVES: We present two cases of onycholysis associated with capecitabine in women with advanced breast cancer, who were initially referred for evaluation of onychomycosis and review the literature on capecitabine.
CONCLUSION: Owing to the increased frequency of use of capecitabine for different cancers, physicians should be aware of this side effect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346407     DOI: 10.2310/7750.2008.07028

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  1 in total

Review 1.  Interaction between capecitabine and brivudin in a patient with breast cancer.

Authors:  José M Baena-Cañada; María J Martínez; Obdulia García-Olmedo; Reyes Jiménez-Bárcenas; Pedro Muriel-Cueto
Journal:  Nat Rev Clin Oncol       Date:  2010-01       Impact factor: 66.675

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.